Literature DB >> 27162585

Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx.

Kafil Akhtar1, Anjum Ara1, Shahid A Siddiqui2, Rana K Sherwani1.   

Abstract

OBJECTIVES: We sought to study the expression of epithelial-to-mesenchymal transition markers E-cadherin and vimentin in precancerous lesions of the oral cavity and oropharynx and to use the specific pattern of expression to predict invasiveness.
METHODS: This cross-sectional study looked at 87 cases of oral and oropharyngeal lesions obtained between December 2012 and November 2014 in the Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, India. Fifty-three biopsies from the buccal mucosa, tongue, and pharynx and 34 resected oral specimens were evaluated for premalignant and malignant lesions using hematoxylin and eosin and immunohistochemical stains. Immunohistochemical expression of epithelial marker E-cadherin and mesenchymal marker vimentin was evaluated wherever possible. Slides were examined for staining pattern (cytoplasmic or membrane), proportion, and intensity of staining of tumor cells. Patients follow-up and therapy related changes were also studied.
RESULTS: There were 64 premalignant and 23 malignant cases in our study with 65 (74.7%) cases seen in males and 22 (25.3%) cases seen in females. The majority of malignant cases, (n = 15; 64.2%) were seen in the fifth and sixth decades of life while most of the premalignant lesions (n = 36; 56.4%) were seen in the fourth and fifth decade. Amongst the 64 premalignant oral lesions, leukoplakia comprised of 14 cases (21.9%), of which three cases had associated mild to moderate dysplasia. The majority of premalignant lesions showed strong E-cadherin expression and decreased expression of vimentin with negative and weak expression in both dysplasias and carcinoma in situ (p = 0.013). E-cadherin expression was significantly reduced in invasive carcinomas compared to dysplasias and carcinoma in situ and the difference in immunoreactivity was statistically significant (p < 0.050). Vimentin expression increased as the tumor progressed from dysplasias to carcinoma in situ to invasive carcinomas (p < 0.050).
CONCLUSIONS: Invasiveness of cancer can be analyzed using E-cadherin and vimentin immunohistochemical stains, which can help in predicting tumor behavior. These biomolecules can also be used as biomarkers for further research on the microinvasion of oral cancers for early diagnosis.

Entities:  

Keywords:  E-cadherin; Immunohistochemistry; Oral Neoplasms; Precancerous Conditions; Vimentin

Year:  2016        PMID: 27162585      PMCID: PMC4852082          DOI: 10.5001/omj.2016.33

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  15 in total

Review 1.  Oral lichen planus: a potentially premalignant lesion.

Authors:  S Silverman
Journal:  J Oral Maxillofac Surg       Date:  2000-11       Impact factor: 1.895

2.  E-cadherin expression during progression of squamous intraepithelial lesions in the uterine cervix.

Authors:  K Kaplanis; A Kiziridou; V Liberis; C Destouni; G Galazios
Journal:  Eur J Gynaecol Oncol       Date:  2005       Impact factor: 0.196

3.  Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study.

Authors:  Gurkiran Kaur; Sunitha Carnelio; Nirmala Rao; Laxmi Rao
Journal:  Indian J Dent Res       Date:  2009 Jan-Mar

Review 4.  Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996.

Authors:  R B Zain; N Ikeda; P C Gupta; S Warnakulasuriya; C W van Wyk; P Shrestha; T Axéll
Journal:  J Oral Pathol Med       Date:  1999-01       Impact factor: 4.253

5.  Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias.

Authors:  C A Waldron; W G Shafer
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

6.  The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study.

Authors:  Erik H van der Meij; Kees-Pieter Schepman; Isaäc van der Waal
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2003-08

Review 7.  Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers.

Authors:  A Mashberg; A Samit
Journal:  CA Cancer J Clin       Date:  1995 Nov-Dec       Impact factor: 508.702

8.  Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression.

Authors:  Hai-Xia Fan; Shan Wang; Hong Zhao; Nian Liu; Dong Chen; Miao Sun; Jin-Hua Zheng
Journal:  Med Oncol       Date:  2014-06-12       Impact factor: 3.064

Review 9.  The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.

Authors:  Brett G Hollier; Kurt Evans; Sendurai A Mani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-26       Impact factor: 2.673

10.  Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression.

Authors:  Na-Hye Myong
Journal:  Korean J Pathol       Date:  2012-08-23
View more
  9 in total

1.  Role of Vimentin and E-cadherin Expression in Premalignant and Malignant Lesions of Oral Cavity.

Authors:  Sandesh Kumar Gupta; Sunita Agarwal; Shashank Nath Singh; Ritu Sehra; Prem Singh Jat; Pawan Singhal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-06-09

2.  Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.

Authors:  Li-Guo Liu; Xue-Bing Yan; Ru-Ting Xie; Zhi-Ming Jin; Yi Yang
Journal:  Med Sci Monit       Date:  2017-06-14

3.  Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo.

Authors:  Hao Cheng; Chenglin Lu; Ribo Tang; Yiming Pan; Shanhua Bao; Yudong Qiu; Min Xie
Journal:  Oncotarget       Date:  2017-02-14

4.  Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study.

Authors:  I Ilangani Sathish; Kannan Asokan; Krithika C L; Arvind Ramanathan
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

5.  Assessment of epithelial-mesenchymal transition signatures in oral submucous fibrosis.

Authors:  R Shesha Prasad; Anuradha Pai; K Shyamala; Abhishek Bhadranna; Sadhana Shenoy; Anisha Yaji
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

Review 6.  Biomarker Potential of Vimentin in Oral Cancers.

Authors:  Saie Mogre; Vidhi Makani; Swapnita Pradhan; Pallavi Devre; Shyam More; Milind Vaidya; Crismita Dmello
Journal:  Life (Basel)       Date:  2022-01-20

7.  Demographic study of 366 cases of oral leukoplakia and immunohistochemical analysis - An institutional study.

Authors:  Manisha Sardar Ahire; Zaneta Ivy D Souza; Tabita Joy Chettiankandy; Saurabh R Nagar; Anuradha Sinha; Jagdish V Tupkari
Journal:  J Oral Maxillofac Pathol       Date:  2022-01-11

8.  Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma - An immunohistochemical study.

Authors:  Nagiredla Puneeta; Tummidi Santosh; Isha Mishra; Pravin Gaikwad; Anshuta Sahu
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28

9.  Evaluation of immunohistochemical expression of epithelial- mesenchymal transition markers E-cadherin, Twist and Snail in oral submucous fibrosis and their possible association with malignant transformation.

Authors:  Mahadevi B Hosur; Rudrayya S Puranik; Shrinivas S Vanaki; Surekha Rudrayya Puranik; M Sudhakara; Sushma Das
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.